WHO ICTRP trial

The stress hormone COrtisol and the development of MEtabolic Syndrome and…

NL-OMON54740 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting

Key facts

Trial ID NL-OMON54740
Public title The stress hormone COrtisol and the development of MEtabolic Syndrome and Cardiovascular DIseases Unravelling the cause(s) of hypercortisolism in obesity: Investigating the influence of the liver, gut and immune system
Scientific title The stress hormone COrtisol and the development of MEtabolic Syndrome and Cardiovascular DIseases Unravelling the cause(s) of hypercortisolism in obesity: Investigating the influence of the liver, gut and immune system - COMEDI
Primary sponsor Erasmus MC, Universitair Medisch Centrum Rotterdam
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Recruiting
Study type Observational invasive
Countries The Netherlands
Conditions metabolic syndrome Obesity;10001353;10003018;10017998;metabolic syndrome;Obesity
Interventions ;Cortisol;gut microbiome;liver steatosis;obesity
Registration date Jun 20, 2023
Target size 200
Secondary IDs NL68591.078.18
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations